Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs4846048
rs4846048
0.010 GeneticVariation BEFREE The preliminary report revealed that the SNP rs4846048 of MTHFR enhanced the risk of CC through association with miR-522, which further regulated cell viability and apoptosis in Hela cells. 31750632

2020

dbSNP: rs55763075
rs55763075
0.010 GeneticVariation BEFREE PCR-DNA analysis was used to explore the genotype of the SNPs (rs4846048 and rs55763075) of the MTHFR 3'-UTR as well as the association between allelic frequencies and the CC risk. 31750632

2020

dbSNP: rs10426502
rs10426502
0.010 GeneticVariation BEFREE The stratified analysis showed that <i>TNFAIP8L1</i>-rs10426502, -rs1060555, and <i>FLT1</i>-rs9513111 were associated with a decreased risk of cervical cancer amongst people older than 43 years. 31289124

2019

dbSNP: rs1058808
rs1058808
0.010 GeneticVariation BEFREE <b>Conclusions:</b> Our results suggested that the combination of <i>HER2</i> rs1136201and rs1058808 was significantly associated with the susceptibility of CCa. 30719131

2019

dbSNP: rs1060555
rs1060555
0.010 GeneticVariation BEFREE The stratified analysis showed that <i>TNFAIP8L1</i>-rs10426502, -rs1060555, and <i>FLT1</i>-rs9513111 were associated with a decreased risk of cervical cancer amongst people older than 43 years. 31289124

2019

dbSNP: rs1143627
rs1143627
0.010 GeneticVariation BEFREE Our result revealed IL-1B rs1143627-AA (OR = 1.98, p = 0.029) and rs16944-GG (OR = 2.01, p = 0.025) was associated with an increased risk of cervical cancer. 31222982

2019

dbSNP: rs1143630
rs1143630
0.010 GeneticVariation BEFREE Haplotype ″TGA″ in the block (rs1143630, rs1143627, and rs16944) significantly decreased the susceptibility of cervical cancer (OR = 0.53, p = 0.0007). 31222982

2019

dbSNP: rs11543848
rs11543848
0.010 GeneticVariation BEFREE Here, the association between EGFR R497K (rs11543848) and -216G/T (rs712829) SNPs and radiochemotherapy response in cervical cancer was investigated. 31254173

2019

dbSNP: rs11568785
rs11568785
0.010 GeneticVariation BEFREE Multivariable logistic regression of cancer status in an over-dominant TGFB1 rs1800469/TGFBR1 rs11568785 model demonstrated a 3.03-fold reduction in cervical cancer odds. 31435875

2019

dbSNP: rs11655237
rs11655237
0.010 GeneticVariation BEFREE Our results indicate that LINC00673 rs11655237 is associated with increased risk of cervical cancer, possibly by downregulating LINC00673 expression in cervical tissues. 30286619

2019

dbSNP: rs11674595
rs11674595
0.010 GeneticVariation BEFREE Moreover, haplotype "T/A" of rs11674595/rs4851527 (adjusted OR = 0.73, 95% CI = 0.54-0.98, p = 0.037) and "T/C" of rs719250/rs3218896 (adjusted OR = 1.61, 95% CI = 1.10-2.36, p = 0.015) exhibited protective and risky effects for Uygur individuals on cervical cancer development, respectively. 30460760

2019

dbSNP: rs1195571
rs1195571
0.010 GeneticVariation BEFREE For the individuals older than 43, rs4604006 (VEGF-C) was related to an increased cervical cancer risk under codominant model (p = .035), and rs12646659 was significantly associated with a reduced cervical cancer risk in allele, dominant, log-additive models (allele: p = .028; codominant: p = .037; log-additive: p = .037) However, there were no significant correlation of rs1000611 (VEGFR-2) and rs1195571 (VEGFR-3) with cervical cancer risk in Chinese Uygur population. 31478352

2019

dbSNP: rs12646659
rs12646659
0.010 GeneticVariation BEFREE Our study firstly provided evidence that rs4604006 and rs12646659 of VEGF-C gene were related to the susceptibility of cervical cancer in Chinese Uygur population. 31478352

2019

dbSNP: rs1800587
rs1800587
0.010 GeneticVariation BEFREE The results also suggest a high risk of cancer susceptibility in patients carried rs1800587 polymorphism, of which draw out form allelic and homozygote models in overall studies, especially for cervical cancer. 31359795

2019

dbSNP: rs1927911
rs1927911
0.010 GeneticVariation BEFREE CC and CT genotypes of TLR4 rs11536889 and rs1927911 respectively, and TC, CC genotypes of TLR9 rs187084, as well as minor alleles of TLR4 rs4986790 and TLR9 rs187084, were associated with the increased risk of cervical cancer. 31278284

2019

dbSNP: rs2043556
rs2043556
0.010 GeneticVariation BEFREE Because genetic variants in microRNAs (miRNAs) or their surrounding regions can alter miRNA processing, expression and final biological function, we investigated whether miRNA single-nucleotide polymorphisms (SNPs) are associated with cervical cancer (CC) susceptibility.Common miRNA SNPs (i.e. miR-146a rs2910164, miR-149 rs2292832, miR-196a2 rs11614913, miR-499 rs3746444, miR-605 rs2043556 and miR-618 rs2682818) were genotyped in the 954 patients and 1339 controls. 30852614

2019

dbSNP: rs2227983
rs2227983
0.010 GeneticVariation BEFREE The R497K SNP might be a genetic marker for prediction of radiochemotherapy response and the risk of recurrence and/or metastasis in patients with cervical cancer. 31254173

2019

dbSNP: rs2292832
rs2292832
0.010 GeneticVariation BEFREE Therefore, the rs2292832 polymorphism might influence CC susceptibility through modulation of the procession of pre-miR-149 to mature miRNAs. 30852614

2019

dbSNP: rs2682818
rs2682818
0.010 GeneticVariation BEFREE Because genetic variants in microRNAs (miRNAs) or their surrounding regions can alter miRNA processing, expression and final biological function, we investigated whether miRNA single-nucleotide polymorphisms (SNPs) are associated with cervical cancer (CC) susceptibility.Common miRNA SNPs (i.e. miR-146a rs2910164, miR-149 rs2292832, miR-196a2 rs11614913, miR-499 rs3746444, miR-605 rs2043556 and miR-618 rs2682818) were genotyped in the 954 patients and 1339 controls. 30852614

2019

dbSNP: rs2839698
rs2839698
0.010 GeneticVariation BEFREE Although genotypes TT in LncRNA H19 rs2839698 and GG in rs3741219 are related to some poor clinicopathological parameters of cervical cancer, only pelvic lymph node status could predict 5 year patient survival significantly. 31772651

2019

dbSNP: rs3218896
rs3218896
0.010 GeneticVariation BEFREE Moreover, haplotype "T/A" of rs11674595/rs4851527 (adjusted OR = 0.73, 95% CI = 0.54-0.98, p = 0.037) and "T/C" of rs719250/rs3218896 (adjusted OR = 1.61, 95% CI = 1.10-2.36, p = 0.015) exhibited protective and risky effects for Uygur individuals on cervical cancer development, respectively. 30460760

2019

dbSNP: rs3219489
rs3219489
0.010 GeneticVariation BEFREE These findings clearly highlight associations between the MUTYH Gln324His (CAG/CAC) polymorphism and susceptibility to CSCC, HR-HPV infection and specific prognostic factors, supporting the utility of this variant as an early indicator for patients at high risk of cervical carcinoma. 31027119

2019

dbSNP: rs3741219
rs3741219
0.010 GeneticVariation BEFREE Although genotypes TT in LncRNA H19 rs2839698 and GG in rs3741219 are related to some poor clinicopathological parameters of cervical cancer, only pelvic lymph node status could predict 5 year patient survival significantly. 31772651

2019

dbSNP: rs3787016
rs3787016
0.010 GeneticVariation BEFREE Collectively, the POLR2E rs3787016 polymorphism may be a valuable biomarker for female breast and cervical cancer predisposition. 30846411

2019

dbSNP: rs42032
rs42032
0.010 GeneticVariation BEFREE Rs8179, rs42032, and rs42033 were associated with susceptibility to high-grade cervical cancer in different genetic models as well (p < 0.05). 30829464

2019